Ann DeWitt
Direktor/Vorstandsmitglied bei Cambridge Crops, Inc.
Profil
Ann is a General Partner at The Engine.
She serves as a Board Member for Biobot Analytics, Cellino, Kano Therapeutics, Kytopen, Lucy Therapeutics, Quaise, Syzygy Plasmonics, and Vaxess Technologies.
Ann was most recently at Sanofi where she held senior roles in business development and strategic venture investment.
Prior to Sanofi, she was at Flagship Pioneering.
Ann started her career in R&D at 3M Company, working across fields of materials, biology and engineering.
Ann holds an MBA from Harvard and a PhD in Chemical Engineering from MIT.
She served on the Board of Women in the Enterprise of Science and Technology and is on the Life Science Council of Springboard Enterprises.
She serves as a Key Advisory Board member of Harvard’s Blavatnik Fellowship in Life Science Entrepreneurship and is a member of Investment Advisory Committee for Prime Coalition.
Aktive Positionen von Ann DeWitt
| Unternehmen | Position | Beginn |
|---|---|---|
The Engine Accelerator, Inc.
 The Engine Accelerator, Inc. Investment ManagersFinance The Engine Accelerator, Inc. (The Engine) is a venture capital firm founded in 2016. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01.01.2019 |
Cambridge Crops, Inc.
 Cambridge Crops, Inc. Wholesale DistributorsDistribution Services Cambridge Crops, Inc. provides edible and natural biomaterial coating services. It uses salt and water to extract the protein from silk to create an edible protective layer that keeps food fresh for longer. The company was founded by Fiorenzo Omenetto, Livio Valenti, Jacques-Henry Grislain and Benedetto Marelli and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | - |
Vaxess Technologies, Inc.
 Vaxess Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
Quaise Energy, Inc.
 Quaise Energy, Inc. Oilfield Services/EquipmentIndustrial Services Quaise Energy, Inc. engages in the development and commercialization of novel millimeter wave drilling systems to harness geothermal energy. Its technology enables the clean energy transition by accessing the largest source of power-dense clean energy. The company was founded in 2018 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
Lucy Therapeutics, Inc.
 Lucy Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Lucy Therapeutics, Inc. operates as a biotech firm. It offers a novel approach to drug discovery by drugging targets associated with early disease pathogenesis. The company was founded by Amy Ripka and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
Kano Therapeutics, Inc.
 Kano Therapeutics, Inc. BiotechnologyHealth Technology Kano Therapeutics, Inc. is a biotechnology company that specializes in providing correction of gene-length stretches of DNA through a new class of biomaterial products. The company is based in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ann DeWitt
| Unternehmen | Position | Ende |
|---|---|---|
Sanofi Ventures
 Sanofi Ventures Investment ManagersFinance Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts. | Director of Investments | 31.05.2016 |
Permeon Biologics, Inc.
 Permeon Biologics, Inc. BiotechnologyHealth Technology Permeon Biologics, Inc. develops intracellular biotherapeutics platform to enhance drug delivery. Its intraphilin technology platform leverages research on remodeling the surfaces of proteins to permit cell penetration without losing their structure or activity; and enables functional proteins to replace or restore defective pathways inside cells that cause disease. The company was founded by Douglas G. Cole, David R. Liu, John W. Ripple, and Noubar B. Afeyan in 2008 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 31.12.2012 |
Kytopen Corp.
 Kytopen Corp. Miscellaneous Commercial ServicesCommercial Services Kytopen Corp. engages in the provision of technology solutions. It develops genetically engineered cells that modifies microorganisms. The company was founded by Paulo A. Gracia and Cullen R. Buie in 2017 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Ann DeWitt
| University of Illinois | Undergraduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
| Harvard University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Sanofi Ventures
Sanofi Ventures Investment ManagersFinance Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Permeon Biologics, Inc.
Permeon Biologics, Inc. BiotechnologyHealth Technology Permeon Biologics, Inc. develops intracellular biotherapeutics platform to enhance drug delivery. Its intraphilin technology platform leverages research on remodeling the surfaces of proteins to permit cell penetration without losing their structure or activity; and enables functional proteins to replace or restore defective pathways inside cells that cause disease. The company was founded by Douglas G. Cole, David R. Liu, John W. Ripple, and Noubar B. Afeyan in 2008 and is headquartered in Cambridge, MA. | Health Technology |
ImmuneXcite, Inc.
 ImmuneXcite, Inc. Pharmaceuticals: MajorHealth Technology ImmuneXcite, Inc. operates as a biopharmaceutical company which develops monoclonal antibodies for cancer. The firm provides nivel immuno-incology technology platform, which leverages both the innate and adaptive immune responses to selectively treat a wide range of tumor types. The company was Ifat Rubin-Bejerano, Gerald R. Fink and Yaniv Bejerano and is headquartered in Waltham, MA. | Health Technology |
The Engine Accelerator, Inc.
The Engine Accelerator, Inc. Investment ManagersFinance The Engine Accelerator, Inc. (The Engine) is a venture capital firm founded in 2016. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Cambridge Crops, Inc.
Cambridge Crops, Inc. Wholesale DistributorsDistribution Services Cambridge Crops, Inc. provides edible and natural biomaterial coating services. It uses salt and water to extract the protein from silk to create an edible protective layer that keeps food fresh for longer. The company was founded by Fiorenzo Omenetto, Livio Valenti, Jacques-Henry Grislain and Benedetto Marelli and is headquartered in Boston, MA. | Distribution Services |
Kytopen Corp.
Kytopen Corp. Miscellaneous Commercial ServicesCommercial Services Kytopen Corp. engages in the provision of technology solutions. It develops genetically engineered cells that modifies microorganisms. The company was founded by Paulo A. Gracia and Cullen R. Buie in 2017 and is headquartered in Cambridge, MA. | Commercial Services |
Vaxess Technologies, Inc.
Vaxess Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA. | Commercial Services |
Quaise Energy, Inc.
Quaise Energy, Inc. Oilfield Services/EquipmentIndustrial Services Quaise Energy, Inc. engages in the development and commercialization of novel millimeter wave drilling systems to harness geothermal energy. Its technology enables the clean energy transition by accessing the largest source of power-dense clean energy. The company was founded in 2018 and is headquartered in Cambridge, MA. | Industrial Services |
Lucy Therapeutics, Inc.
Lucy Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Lucy Therapeutics, Inc. operates as a biotech firm. It offers a novel approach to drug discovery by drugging targets associated with early disease pathogenesis. The company was founded by Amy Ripka and is headquartered in Cambridge, MA. | Commercial Services |
Kano Therapeutics, Inc.
Kano Therapeutics, Inc. BiotechnologyHealth Technology Kano Therapeutics, Inc. is a biotechnology company that specializes in providing correction of gene-length stretches of DNA through a new class of biomaterial products. The company is based in Cambridge, MA. | Health Technology |
